In this issue:
COVID-19 in patients with haematological malignancies
BIVV001 fusion protein as FVIII replacement in haemophilia A
Ruxolitinib + interferon-α2 in polycythaemia vera/myelofibrosis
Chemoradiotherapy with temozolomide after high-dose methotrexate in primary CNS lymphoma
Romiplostim immunogenicity in clinical trials and postmarketing
TBI vs. chemotherapy-based MAC after haematopoietic cell transplant in AML
Rozanolixizumab in primary ITP
Rivaroxaban vs. LMWH in cancer-associated thromboembolism
Ixazomib-dexamethasone-rituximab in treatment-naive Waldenström macroglobulinaemia
Clinical outcomes and prognostic factors in Richter syndrome
Please login below to download this issue (PDF)